http://www.biofortuna.com Just another WordPress weblog Fri, 27 Nov 2009 12:19:14 +0000 http://backend.userland.com/rss092 en Lab901 (Edinburgh, UK) and Biofortuna (Liverpool, UK) today announced that they will collaborate on the launch of an automated PCR based diagnostics system for the rapid detection of certain HLA-related diseases such as Coeliac disease. Lab901 will be optimising its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range ... http://www.biofortuna.com/index.php/news/biofortuna-and-lab901-to-collaborate-on-rapid-genotyping-projects/ Biofortuna were today approved by Lloyds Register Quality Assurance for the design and manufacture of genotyping and phenotyping in-vitro diagnostic products which enables us to sell CE marked products. The rapid progress in quality management is testament to the dedication and skill of our quality team and our consultant Dave Ashworth ... http://www.biofortuna.com/index.php/news/biofortuna-achieve-iso-90012008-and-iso-134852003/ Over 200 people from the Northwest's biomedical sector gathered last night (Thursday 12th November) at the prestigious annual Northwest Biomedical Awards at Mere Golf and Country Club.  The awards, organised by Bionow, the Northwest Regional Development Agency's (NWDA) biomedical cluster support group, were a resounding success and showcased the very ... http://www.biofortuna.com/index.php/news/biofortuna-awarded-the-biomedical-start-up-company-of-the-year-sponsored-by-baker-tilly/ Biofortuna genotyping products utilise novel platforms from our exciting collaborators (links). These links and the product information will appear here closer to launch. http://www.biofortuna.com/index.php/bio-products/platforms/ More details will appear here along with our collaborators information closer to launch. http://www.biofortuna.com/index.php/bio-products/transplant-monitoring/ Andy Bonner was previously Facilities Manager for a major international biotechnology company and comes with a wealth of practical experience in biotechnology operations management and quality systems management. Andy has ten years of direct experience in the production, development and maintenance of in vitro diagnostic biotechnology kits and platforms applied ... http://www.biofortuna.com/index.php/staff-key/andy-bonner/ Mark Reardon is Biofortuna's Software Development Manager. Mark is an experienced software developer who previously worked for fifteen years as an independent software consultant in a wide range of public and private sector businesses and services including a large international biotechnology company. Mark brings to Biofortuna a broad hardware, ... http://www.biofortuna.com/index.php/staff-key/mark-reardon-bsc/ Mark is a serial entrepreneur with a wealth of experience of start-up and early stage businesses and is a director of a number of health and life-science companies, whose technologies range from drug development (anti-cancer) through to medical device development (implantable insulin delivery device). http://www.biofortuna.com/index.php/staff-directors/mark-hurley/ Before co-founding Biofortuna Ltd, David had 7 years R&D experience in developing complex genotyping solutions within Dynal / Invitrogen‚ Transplant Diagnostics division. David specialised in developing and project managing key projects in macro and microarray technologies . He has a BSc in Genetics from the University of Liverpool, and in ... http://www.biofortuna.com/index.php/staff-directors/david-charvill-bsc/ Prior to setting up Biofortuna Ltd, Ben worked for Dynal / Invitrogen‚ Transplant Diagnostics division (previously Dynal Biotech UK) where he was instrumental in developing and maintaining HLA genotyping solutions such as sequence-specific amplification (SSP) and sequence-specific oligonucelotides (SSO) as well as developing novel microarray technology . He has a ... http://www.biofortuna.com/index.php/staff-directors/ben-passey-bsc/